CD8A and neoplasm: When purified WT and Tg CD8+ cells were transferred separately into Rag1−/− immunodeficient hosts followed by E0771 tumor challenge, Tg CD8+ T cells again exhibited more potent antitumor activity than their WT counterparts (Fig. 7g–i).